Yogesh S. Punekar

GlaxoSmithKline R&D
Brentford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective.

Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective.

Journal: PharmacoEconomics

Published: January 12, 2026

Evaluating the Cost of Genomic Testing for Biomarker-Driven Therapies in Oncology.

Evaluating the Cost of Genomic Testing for Biomarker-Driven Therapies in Oncology.

Journal: Oncology and therapy

Published: November 10, 2025

Consensus on evidence gaps and unmet needs in childhood myopia: findings from a European Delphi study with eye care professionals and payers.

Consensus on evidence gaps and unmet needs in childhood myopia: findings from a European Delphi study with eye care professionals and payers.

Journal: BMJ open ophthalmology

Published: October 14, 2025

Consensus on evidence gaps and unmet needs in childhood myopia: findings from a European Delphi study with eye care professionals and payers.

Consensus on evidence gaps and unmet needs in childhood myopia: findings from a European Delphi study with eye care professionals and payers.

Journal: BMJ open ophthalmology

Published: October 14, 2025

Direct and indirect medical costs associated with transfusion-dependent beta-thalassemia in Brazil, Thailand, and India.

Direct and indirect medical costs associated with transfusion-dependent beta-thalassemia in Brazil, Thailand, and India.

Journal: Therapeutic advances in hematology

Published: April 29, 2025

The burden of hyperkalaemia in chronic kidney disease: a systematic literature review.

The burden of hyperkalaemia in chronic kidney disease: a systematic literature review.

Journal: Clinical kidney journal

Published: February 27, 2025

Cost-effectiveness of companion BRCA testing and adjuvant olaparib treatment in patients with BRCA-mutated high-risk HER2-negative early breast cancer.

Cost-effectiveness of companion BRCA testing and adjuvant olaparib treatment in patients with BRCA-mutated high-risk HER2-negative early breast cancer.

Journal: Frontiers in oncology

Published: June 10, 2024

Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States.

Cost-effectiveness and budget impact of dolutegravir/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States.

Journal: Journal of managed care & specialty pharmacy

Published: June 29, 2021

Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis.

Correction to: Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis.

Journal: BMC infectious diseases

Published: April 13, 2021

Effectiveness and safety of dolutegravir two-drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta-analysis of real-world evidence.

Effectiveness and safety of dolutegravir two-drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta-analysis of real-world evidence.

Journal: HIV medicine

Published: December 01, 2020

Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis.

Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis.

Journal: BMC infectious diseases

Published: October 30, 2020

Prevalence, determinants, and impact of suboptimal adherence to HIV medication in 25 countries.

Prevalence, determinants, and impact of suboptimal adherence to HIV medication in 25 countries.

Journal: Preventive medicine

Published: March 25, 2020

Showing 1-12 of 44

Last Updated: 09/26/2026